{"id":"W3096697285","doi":"10.1182/blood-2020-136344","title":"A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Tolerability; CD20; Lymphoma; Internal medicine; Refractory (planetary science); Oncology; Follicular lymphoma; Antibody; Phases of clinical research; Gastroenterology; Chemotherapy; Adverse effect; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001814035,0.00177688,0.001468801,0.0003628221,0.0003618576,0.000710168,0.0007881701,0.0008598574,0.002995434],"category_scores_gemma":[0.0006969195,0.0005288062,0.001047988,0.0003042337,0.0008209043,0.0007701985,0.0004609482,0.002537758,0.0007652671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007750955,"about_ca_system_score_gemma":0.001453619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00148405,"about_ca_topic_score_gemma":0.003641097,"domain_scores_codex":[0.9995709,0.0002089534,0.00001709333,0.00008554968,0.00003784677,0.00007960993],"domain_scores_gemma":[0.9994293,0.00007683106,0.00008413541,0.00006297432,0.00003836126,0.000308438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5997104,0.1693196,0.02264643,0.000935108,0.00198605,0.0006412565,0.0006848132,0.00341489,0.09333499,0.0002750188,0.005357451,0.101694],"study_design_scores_gemma":[0.4304852,0.5308731,0.02774989,0.00002201708,0.0005949662,0.0005172055,0.0001179591,0.001190629,0.004946372,0.0001495017,0.003317862,0.00003529369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946956,0.0006822133,0.000478364,0.0001844516,0.00006266403,0.001758612,0.00114507,0.00006801941,0.0009251615],"genre_scores_gemma":[0.9881583,0.001059252,0.001892734,0.0006816854,0.0001220254,0.001999368,0.003867842,0.00003950908,0.00217937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002995434,"threshold_uncertainty_score":0.01002073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0207808150907924,"score_gpt":0.2958991003380819,"score_spread":0.2751182852472895,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}